Important Risk Warning: Investing in OTC (Over-The-Counter) micro-cap companies carries significant risk. Information can be scarce or outdated, liquidity is often low, and many companies have unproven business models. This information is for educational purposes only and not investment advice. Always conduct thorough, independent due diligence and consult with a financial advisor before making any investment decisions.
| Company (Ticker) | Products / Platform Focus | Outlook (Based on Recent Information) |
|---|---|---|
| ReelTime Media (OTCID: RLTR) |
Launching “Reel Intelligence” (RI) platform. Key features include:
|
Recent news (July 21, 2025) indicates a significant stock surge (51.72% in one day, 134% in six days), attributed to growing investor excitement over their RI platform, which claims a “clear technological lead.” CEO emphasizes its “smarter, cleaner, and more capable, and environmentally sustainable” nature. This strong short-term rally makes it appear promising. However, sustained outperformance and successful commercialization remain critical for this OTC company. |
| VERSES AI (OTCMKTS: VRSSF / VRSSD) | Cognitive computing company specializing in next-generation AI. Focus is on sophisticated AI systems, likely involving intelligent agents and spatial computing for various applications. |
Filed audited annual financial statements for fiscal year ended March 31, 2025 (July 2, 2025). Demonstrated strong revenue growth of ~7% over the last twelve months to $11 billion and maintains a “GOOD” financial health rating by InvestingPro analysis. However, the stock has shown high volatility, hitting a 52-week low recently after trading as high as $43.20 (Jan 3, 2025). The outlook is mixed, with good financial health but high stock volatility. |
| NeuroOne Medical Technologies Corp (OTCMKTS: NMTC) |
Develops medical technologies for neurological disorders. Core products are FDA-cleared electrodes for brain use (diagnostic & therapeutic). AI is applicable for:
|
Secured a key U.S. patent (July 23, 2025) for neural probe devices. Positive clinical success reported for their OneRF® Ablation System, with a patient seizure-free for over a year (June 23, 2025). Has exclusive partnerships with Zimmer Biomet and Mayo Clinic. Annual Net Profit for Sep-2024 is projected at $-12 Million, a -3.9% YoY growth (still negative profit). Revenue growth was high (772.60%) in an earlier period, but gross profit and operating income remain negative. These indicate ongoing losses despite product advancements. |
| Treatment.com AI Inc. (OTCMKTS: TREIF) |
Focuses on AI in the healthcare sector. Key products and initiatives:
|
Actively engaged in marketing (July 18, 2025) and expanding partnerships. Trailing 12-month revenue is very low ($28.19K CAD) and net income is significantly negative (-$2.01M CAD for Sep ’23 TTM). Operating income consistently negative. While the market cap is $28.25M, indicating investor belief, the current financial performance shows it’s far from profitability and has a significant cash burn. Upcoming earnings are Aug 28, 2025. |
| Artificial Intelligence Technology Solutions Inc. (OTCMKTS: AITX) |
Leader in AI-driven security solutions via its subsidiary, Robotic Assistance Devices Inc. (RAD). Products automate security and operational needs:
|
Reported significant revenue growth ($6.8M trailing 12-month revenue as of May 31, 2025). Aiming for cash flow positivity. Market cap of $32.59M. However, recent stock movements (July 25, 2025) show decline (-0.95% today) and overall slump, with shares hitting a two-month low due to “disappointing recent results and lack of meaningful news flow” and concerns about share dilution. This indicates a challenging short-term outlook despite past growth metrics and stated goals. |
| Hapbee Technologies (OTCQB: HAPBF) |
Wearable wellness technology company with a proprietary platform delivering low-power digital signals via wearables to influence user feelings (focus, relaxation, sleep). AI integration:
|
Achieved its first-ever quarterly profit in Q2 2025 (July 18, 2025), a significant milestone ($17,988 net income vs. $178,984 loss in Q1). Reported strong revenue growth (26% QoQ to $520,323, 114% YoY) and improved gross margins (58%). Device sales and subscription revenue surged. Recent insider purchases and new board appointments indicate positive internal sentiment and a push for global expansion. Analysts project continued earnings growth for FY2025 and FY2026, marking a positive turnaround. |
| Nextech3D.AI Corporation (OTCMKTS: NEXCF) |
Specializes in augmented reality (AR) technologies and 3D models for e-commerce. AI is crucial for:
|
Will release Fiscal 2024 audited financials on July 29, 2025. Quarterly revenue reported at $0.21 million, “below analysts’ expectations of $1.02 million.” Trailing EPS of -$0.04. Expected earnings growth from ($0.05) to ($0.04) per share next year, indicating continued losses. Secured new contracts, and client renewals cite strong ROI, but financials show ongoing unprofitability and revenue missing expectations. Stock price recently declined (-3.28% on July 25, 2025). |
| Genesis AI Corp (OTCPK: AIGFF) |
States focus on cybersecurity solutions for business intelligence, aiming to increase security posture and reduce risk. Also has a military-grade cybersecurity platform. Recent news highlights:
|
Financial health is a major concern: **Negative shareholder equity** (-$640,769 as of July 16, 2025), declining earnings (-24.8% per year over past 5 years), and **less than one year of cash runway**. Operates with very low revenue (US$579.37k) and significant negative net income (-US$665.09k). Profit margin is -114.80%. Significantly underperformed the US Software industry and the broader US Market. Very small market cap ($691,696 – $1.06M), making it highly speculative and a high-risk investment. |
| Generative AI Solutions Corp (OTCMKTS: AICOF) | Company name indicates a focus on “Generative AI Solutions.” However, Q1 2025 filing mentioned a subsidiary, “Poda Lifestyle And Wellness Ltd,” which is engaged in “heat-not-burn smoking products,” creating ambiguity regarding its core AI focus. Recent news mentions “new AI initiatives and investor engagement.” |
Significant compliance issue: Faced “**Extended Delay in Annual Financial Statements Filing**” (July 18, 2025), leading to a Management Cease Trade Order (MCTO) by the British Columbia Securities Commission. This restricts the CEO and CFO from trading company securities. This is a major red flag indicating poor corporate governance and financial transparency. Despite a stated generative AI focus, operational and financial uncertainty makes their outlook highly speculative and risky. Market Cap $8.98M. |
| AI/ML Innovations Inc. (PNK: AIMLF) |
Global technology company focused on AI and machine learning (ML), initially emphasizing digital healthcare. Products include:
|
Classified as a “**Sucker Stock**” by Stockopedia (July 18, 2025), a significant warning. Share price has significantly underperformed the S&P500 over recent periods. Very small market cap ($6.37M) and very low trailing 12-month revenue ($146K) with negative EBITDA and net income. Current stock price is $0.036 (July 25, 2025). While AI healthcare products sound promising, current financial performance and “Sucker Stock” classification indicate a very high-risk profile. |
| Fobi AI Inc. (OTCMKTS: FOBIF) | Data intelligence company offering AI, automated marketing, contact tracing, and contactless solutions for “brick-and-mortar space.” “Fobi” is a plug-and-play solution providing real-time insights and personalized engagement. Pivoting towards Web3 and cybersecurity. |
Recently appointed a new Chief Technology Officer (July 21, 2025) with expertise in AI and blockchain, signaling a strategic shift. However, revenue has been declining (-45.18% in quarter ending March 31, 2024, and -22.77% in last twelve months). Trailing 12-month revenue is $1.94M CAD. While the strategic pivot could open new markets, the current revenue decline and small market cap ($6.60M) indicate significant challenges. Also announced CFO transition and sale of German subsidiary (July 2025). |
| Quantgate Systems Inc. (OTCMKTS: QGSI) |
Fintech company developing real-time market sentiment and perception analysis systems for financial markets. Flagship product:
|
Trailing 12-month revenue is very low ($168K) with negative profitability metrics (e.g., Return on Assets -30.61%). Market cap is $4.57M. Stock shows a “**Strong Sell**” technical rating (July 22, 2025) and extremely low liquidity (Quick Ratio 0.00, Current Ratio 0.02, indicating poor financial strength). Despite being in the AI/fintech space, their financial performance and technical signals suggest significant risks and an ongoing struggle. |
**Note:** “Unified Data” was identified as a generic term and not a specific OTC AI company with sufficient public information.
